Völker, L., Kaufeld, J., Miesbach, W., Brähler, S., Reinhardt, M., Kühne, L., . . . Menne, J. (2020). Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura. Blood advances, 4(13), . https://doi.org/10.1182/bloodadvances.2020001973
Chicago Style (17th ed.) CitationVölker, Linus, et al. "Real-world Data Confirm the Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura." Blood Advances 4, no. 13 (2020). https://doi.org/10.1182/bloodadvances.2020001973.
MLA (9th ed.) CitationVölker, Linus, et al. "Real-world Data Confirm the Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura." Blood Advances, vol. 4, no. 13, 2020, https://doi.org/10.1182/bloodadvances.2020001973.